HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

He Huang Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2021Discovery of Dosimertinib, a Highly Potent, Selective, and Orally Efficacious Deuterated EGFR Targeting Clinical Candidate for the Treatment of Non-Small-Cell Lung Cancer.
6/2019Differentially Expressed Gene Screening, Biological Function Enrichment, and Correlation with Prognosis in Non-Small Cell Lung Cancer.
1/2019miR-147b-mediated TCA cycle dysfunction and pseudohypoxia initiate drug tolerance to EGFR inhibitors in lung adenocarcinoma.
1/2018Clinical significance of calcium-binding protein S100A8 and S100A9 expression in non-small cell lung cancer.
11/2014Value of whole-tumor dual-input perfusion CT in predicting the effect of multiarterial infusion chemotherapy on advanced non-small cell lung cancer.
8/2014A double-blind, randomized phase II study of dicycloplatin plus paclitaxel versus carboplatin plus paclitaxel as first-line therapy for patients with advanced non-small-cell lung cancers.
1/2010Predictive significance of bone sialoprotein and osteopontin for bone metastases in resected Chinese non-small-cell lung cancer patients: a large cohort retrospective study.
2/2009[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].
6/2008[Analysis of the relationship between the response after the First-line chemotherapy and the survival in the advanced non-small cell lung cancer.].
4/2008[Efficacy of erlotinib on advanced non-small cell lung cancer].
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


He Huang Research Topics

Disease

187Neoplasms (Cancer)
11/2022 - 05/2002
51Leukemia
01/2022 - 11/2004
43Infections
01/2022 - 11/2002
41Inflammation (Inflammations)
12/2021 - 08/2007
38Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 11/2004
35Graft vs Host Disease (Graft-Versus-Host Disease)
01/2022 - 04/2002
30Hematologic Neoplasms (Hematological Malignancy)
11/2022 - 10/2003
28Fibrosis (Cirrhosis)
07/2022 - 04/2010
27Multiple Myeloma
12/2022 - 06/2004
27Heart Failure
01/2022 - 07/2007
27Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2021 - 11/2004
26Neoplasm Metastasis (Metastasis)
11/2022 - 04/2002
23Atrial Fibrillation
07/2022 - 11/2005
23Lymphoma (Lymphomas)
01/2022 - 05/2002
21Hypoxia (Hypoxemia)
08/2022 - 04/2004
21Myocardial Infarction
12/2021 - 09/2009
18Cardiac Arrhythmias (Arrythmia)
01/2022 - 05/2009
18Hepatocellular Carcinoma (Hepatoma)
01/2021 - 03/2009
17Body Weight (Weight, Body)
12/2022 - 02/2010
16Cardiomegaly (Heart Hypertrophy)
09/2020 - 02/2010
15Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2011
15Stomach Neoplasms (Stomach Cancer)
01/2022 - 12/2005
15Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 11/2010
14Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2022 - 01/2012
14Hemorrhage
01/2022 - 09/2012
14Carcinogenesis
01/2021 - 09/2003
14Colorectal Neoplasms (Colorectal Cancer)
11/2020 - 12/2007
14BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
06/2020 - 10/2003
13Neutropenia
11/2022 - 08/2011
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 12/2002
13Carcinoma (Carcinomatosis)
03/2019 - 11/2002
12Pain (Aches)
01/2022 - 08/2006
12Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 11/2003
11Obesity
01/2022 - 01/2017
11Cytokine Release Syndrome
11/2021 - 01/2016
11Residual Neoplasm
02/2021 - 11/2003
10Thrombosis (Thrombus)
01/2022 - 08/2007
10Hypertension (High Blood Pressure)
01/2022 - 07/2007
10Hypertrophy
09/2020 - 01/2014
9Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 08/2009
9B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 02/2004
9Breast Neoplasms (Breast Cancer)
10/2021 - 12/2008
9Mycoses (Diseases, Fungus)
08/2021 - 05/2013
9Adenocarcinoma
04/2021 - 11/2002
9Glioma (Gliomas)
11/2019 - 07/2005
8Atrial Remodeling
07/2022 - 09/2010
8Thrombocytopenia (Thrombopenia)
01/2022 - 08/2002
8Sepsis (Septicemia)
12/2021 - 01/2013
8Lung Neoplasms (Lung Cancer)
12/2021 - 02/2013
8Disease Progression
01/2021 - 04/2004
8Ischemia
01/2020 - 01/2009
8Acute Promyelocytic Leukemia
01/2020 - 10/2005
7Nasopharyngeal Carcinoma
11/2022 - 12/2003
7Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2022 - 06/2006

Drug/Important Bio-Agent (IBA)

87Proteins (Proteins, Gene)FDA Link
11/2022 - 07/2005
52Chimeric Antigen ReceptorsIBA
01/2022 - 01/2016
37Biomarkers (Surrogate Marker)IBA
06/2022 - 02/2005
26Pharmaceutical PreparationsIBA
06/2022 - 08/2002
23Biological ProductsIBA
11/2022 - 07/2005
21CytokinesIBA
12/2021 - 05/2010
18Messenger RNA (mRNA)IBA
11/2022 - 06/2004
18MicroRNAs (MicroRNA)IBA
01/2021 - 10/2008
16Interleukin-6 (Interleukin 6)IBA
12/2021 - 06/2004
15DNA (Deoxyribonucleic Acid)IBA
01/2021 - 11/2002
14Telomerase (Telomerase Reverse Transcriptase)IBA
10/2021 - 02/2004
13AntigensIBA
01/2021 - 05/2008
13RNA (Ribonucleic Acid)IBA
09/2020 - 10/2008
12Glucose (Dextrose)FDA LinkGeneric
01/2022 - 09/2012
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021 - 09/2009
12Small Interfering RNA (siRNA)IBA
09/2020 - 02/2006
10Peptides (Polypeptides)IBA
01/2022 - 09/2009
9EnzymesIBA
04/2022 - 08/2011
9Rituximab (Mabthera)FDA Link
01/2022 - 08/2009
9Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 10/2011
9CollagenIBA
01/2021 - 04/2010
9Imatinib Mesylate (Gleevec)FDA Link
12/2018 - 05/2009
9Angiotensin IIIBA
10/2018 - 04/2010
8Phosphotransferases (Kinase)IBA
01/2022 - 12/2008
8Bortezomib (Velcade)FDA Link
01/2022 - 12/2009
8Prednisone (Sone)FDA LinkGeneric
01/2022 - 10/2011
8Sirolimus (Rapamycin)FDA Link
11/2021 - 04/2008
8AntibodiesIBA
04/2021 - 01/2011
8Long Noncoding RNAIBA
12/2019 - 12/2016
7Therapeutic UsesIBA
08/2022 - 06/2010
7IronIBA
07/2022 - 04/2010
7ruxolitinibIBA
01/2022 - 12/2019
7Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 10/2006
7SteroidsIBA
01/2022 - 08/2012

Therapy/Procedure

148Therapeutics
12/2022 - 05/2002
69Hematopoietic Stem Cell Transplantation
01/2022 - 01/2010
66Drug Therapy (Chemotherapy)
06/2022 - 08/2002
34Transplantation
11/2022 - 10/2003
17Stem Cell Transplantation
01/2021 - 06/2004
14Immunotherapy
01/2022 - 01/2017
14Radiotherapy
01/2021 - 03/2011
10Deep Brain Stimulation
07/2016 - 05/2005
9Catheter Ablation
01/2022 - 07/2006
9Stents
11/2021 - 03/2011
9Neoadjuvant Therapy
01/2021 - 11/2003
8Ligation
11/2021 - 09/2009